Vanessa Carle - Net Worth and Insider Trading

Vanessa Carle Net Worth

The estimated net worth of Vanessa Carle is at least $5,904 dollars as of 2024-11-13. Vanessa Carle is the Secretary of Lexaria Bioscience Corp and owns about 2,567 shares of Lexaria Bioscience Corp (LEXX) stock worth over $5,904. Details can be seen in Vanessa Carle's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vanessa Carle has not made any transactions after 2024-07-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Vanessa Carle

To

Vanessa Carle Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vanessa Carle owns 1 companies in total, including Lexaria Bioscience Corp (LEXX) .

Click here to see the complete history of Vanessa Carle’s form 4 insider trades.

Insider Ownership Summary of Vanessa Carle

Ticker Comapny Transaction Date Type of Owner
LEXX Lexaria Bioscience Corp 2024-07-31 Secretary

Vanessa Carle Latest Holdings Summary

Vanessa Carle currently owns a total of 1 stock. Vanessa Carle owns 2,567 shares of Lexaria Bioscience Corp (LEXX) as of July 31, 2024, with a value of $5,904.

Latest Holdings of Vanessa Carle

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LEXX Lexaria Bioscience Corp 2024-07-31 2,567 2.30 5,904

Holding Weightings of Vanessa Carle


Vanessa Carle Form 4 Trading Tracker

According to the SEC Form 4 filings, Vanessa Carle has made a total of 1 transactions in Lexaria Bioscience Corp (LEXX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Lexaria Bioscience Corp is the sale of 2,567 shares on July 31, 2024, which brought Vanessa Carle around $10,268.

Insider Trading History of Vanessa Carle

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Vanessa Carle Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Vanessa Carle Ownership Network

Ownership Network List of Vanessa Carle

No Data

Ownership Network Relation of Vanessa Carle

Insider Network Chart

Vanessa Carle Owned Company Details

What does Lexaria Bioscience Corp do?

Who are the key executives at Lexaria Bioscience Corp?

Vanessa Carle is the Secretary of Lexaria Bioscience Corp. Other key executives at Lexaria Bioscience Corp include Chief Financial Officer Gregory Downey , director & 10 percent owner & CEO Christopher Bunka , and CFO Allan Horst Spissinger .

Lexaria Bioscience Corp (LEXX) Insider Trades Summary

Over the past 18 months, Vanessa Carle made 1 insider transaction in Lexaria Bioscience Corp (LEXX) with a net sale of 2,567. Other recent insider transactions involving Lexaria Bioscience Corp (LEXX) include a net purchase of 1,600 shares made by Catherine C. Turkel ,

In summary, during the past 3 months, insiders sold 0 shares of Lexaria Bioscience Corp (LEXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,567 shares of Lexaria Bioscience Corp (LEXX) were sold and 1,600 shares were bought by its insiders, resulting in a net sale of 967 shares.

Lexaria Bioscience Corp (LEXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lexaria Bioscience Corp Insider Transactions

No Available Data

Vanessa Carle Mailing Address

Above is the net worth, insider trading, and ownership report for Vanessa Carle. You might contact Vanessa Carle via mailing address: 100 - 740 Mccurdy Road, Kelowna A1 V1x 2p7.